Quarterly Result22 Jul 2026, 04:23 pm
Dr Reddy's declares Q1 FY27 unaudited consolidated results
AI Summary
Dr Reddy's Laboratories Ltd. announced its unaudited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved the consolidated and standalone financial results prepared under IFRS and Indian Accounting Standards, respectively. Additionally, the Board approved the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel. The appointment of M/s Deloitte Haskins & Sells, LLP as Independent Registered Public Accounting Firm for auditing financial statements for Form 20-F and reviewing interim statements for Form 6-K was also approved.
Key Highlights
- Unaudited consolidated and standalone financial results declared for Q1 FY27.
- Results prepared in compliance with IFRS and Indian Accounting Standards.
- Appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics approved.
- Deloitte Haskins & Sells, LLP appointed as Independent Registered Public Accounting Firm.
- Board meeting held on July 22, 2026, concluded key approvals.
Price Impact
More from DRREDDY